13F

Stock

Trevi Therapeutics, Inc.

TRVI · held by 1 managers

Reported value

$85.5K

Holders

1

+0 new · −0 exited

Holders’ est. mark

−$11.2K

Price effect on 1 books still in the name

Largest holder

$85.5K

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC63.8K$85.5K−$11.2KAdded$56.5K

Positions as of Q4 2023. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.